Posts Tagged ‘XBI’
-
Biotech ETFs for an M&A Boom
May 16th by Tom Lydon
Strong prospects for new drug approvals, a favorable M&A environment, and a positive...
-
Biotech ETFs Weather Market Storm
May 14th by John Spence
One sector that has held up very well amid weakness in the overall market is biotech. In fact, ETFs...
-
Choosing the Right Biotech ETF Exposure
April 20th by Tom Lydon
Coming off the hopeful drug trial tests and lucrative takeover bids, the biotech sector and related...
-
Biotech ETFs Soar on Human Genome Bid, Gilead Drug Results
April 19th by John Spence
Biotech ETFs were the strongest market sector by far in early trading Thursday as portfolio...
-
Biotech ETFs Break Out
January 19th by John Spence
The rally in biotechnology exchange traded funds is going vertical in early 2012 with the sector's...
-
Teva, Cephalon Boost Biotech ETFs
May 2nd by John Spence
Biotechnology exchange traded funds (ETFs) rallied to open the week after Teva Pharmaceutical...
-
April ETF Performance Report
April 29th by Tom Lydon
Markets were in full bloom in April, as corporate earnings helped push markets and exchange traded...
